LETTER
chromatography (7:3) as a brown solid; mp 193–196 °C. IR:
Synthesis of 1,2-Bis(3-indolyl)ethanes
1935
(dec.). IR: 3401, 1579, 1483, 1453, 1423, 1358, 1332, 1260,
1215, 1167, 1092, 1041, 1008, 938, 866, 797, 769, 739, 695,
610 cm–1. 1H NMR [400 MHz, (CD3)2CO]: δ = 10.02 (br s,
1 H, NH), 9.92 (br s, 1 H, NH), 7.63 (d, J = 8.0 Hz, 1 H,
ArH), 7.37 (m, 2 H, 2 × ArH), 7.29 (dd, J = 10.0, 2.5 Hz,
1 H, ArH), 7.23 (d, J = 2.3 Hz, 1 H, ArH), 7.15 (d, J =
2.3 Hz, 1 H, ArH), 7.09 (td, J = 7.5, 1.2 Hz, 1 H, ArH), 7.02
(td, J = 7.5, 1.0 Hz, 1 H, ArH), 6.88 (td, J = 9.1, 2.5 Hz, 1 H,
ArH), 3.13 (m, 4 H, 2 × CH2). 13C NMR [100 MHz,
(CD3)2CO]: δ = 158.3 (d, JC–F = 231.4 Hz, C), 137.8 (C),
134.3 (C), 129.0 (d, JC–F = 9.4 Hz, C), 128.7 (C), 125.0 (CH),
122.8 (CH), 122.0 (CH), 119.4 (CH), 119.3 (CH), 116.9 (d,
JC–F = 4.9 Hz, C), 116.5 (C), 112.9 (d, JC–F = 9.7 Hz, CH),
3393, 2918, 2848, 1483, 1456, 1423, 1330, 1230, 1250,
1223, 1182, 1090, 1047, 1005, 927, 874, 794, 771, 742, 694
cm–1. 1H NMR (400 MHz, DMSO-d6): δ = 9.91 (br s, 1 H,
NH), 9.77 (br s, 1 H, NH), 7.64 (d, J = 7.8 Hz, 1 H, ArH),
7.39 (m, 2 H, 2 × ArH), 7.26 (d, J = 8.2 Hz, 1 H, ArH), 7.15
(d, J = 2.2 Hz, 1 H, ArH), 7.10 (m, 2 H, 2 × ArH), 7.02 (td,
J = 7.4, 1.0 Hz, 1 H, ArH), 6.93 (dd, J = 8.3, 1.0 Hz, 1 H,
ArH), 3.14 (m, 4 H, 2 × CH2), 2.41 (s, 3 H, Me). 13C NMR
(100 MHz, DMSO-d6): δ = 137.8 (C), 136.2 (C), 128.9 (C),
128.7 (C), 128.0 (C), 123.6 (CH), 122.8 (CH), 122.7 (CH),
122.0 (CH), 119.4 (CH), 119.3 (CH), 119.1 (CH), 116.7 (C),
116.2 (C), 112.1 (CH), 111.8 (CH), 27.11 (CH2), 27.07
(CH2), 21.7 (Me). ESI-MS: m/z (%) = 297 (100) [M + Na]+,
170 (9). ESI-HRMS: m/z [M + Na]+ calcd for [C19H18N2 +
Na]+: 297.1362; found: 297.1366.
112.1 (CH), 109.9 (d, JC–F = 26.4 Hz, CH), 104.0 (d, JC–F
=
23.2 Hz, CH), 26.9 (2 × CH2). ESI-MS: m/z (%) = 301 (100)
[M + Na]+, 242 (4), 210 (3). ESI-HRMS: m/z [M + Na]+
calcd for [C18H15FN2 + Na]+: 301.1111; found: 301.1124.
Compound 1f: According to the general procedure, a
mixture of aldehyde 5, 2-iodo-4-(trifluoromethyl)aniline (6f;
47 mg, 0.165 mmol), DABCO (51 mg, 0.450 mmol) and
Pd(OAc)2 (2 mg, 0.008 mmol, 5 mol%) in DMF (1.1 mL)
was heated at 85 °C for 21 h. The title compound (16 mg,
0.049 mmol, 33% over two steps) was obtained after flash
chromatography (7:3) as a brown solid; mp 142–145 °C. IR:
3388, 1458, 1328, 1282, 1261, 1215, 1153, 1130, 1096,
1080, 1044, 1026, 1006, 904, 891, 802, 771, 751, 714, 661
cm–1. 1H NMR [400 MHz, (CD3)2CO]: δ = 10.38 (br s, 1 H,
NH), 9.92 (br s, 1 H, NH), 7.93 (s, 1 H, ArH), 7.61 (d, J =
7.9 Hz, 1 H, ArH), 7.56 (d, J = 8.7 Hz, 1 H, ArH), 7.37 (d,
J = 8.2 Hz, 2 H, 2 × ArH), 7.33 (s, 1 H, ArH), 7.14 (d, J = 2.1
Hz, 1 H, ArH), 7.08 (td, J = 7.4, 0.8 Hz, 1 H, ArH), 7.00 (t,
J = 7.4 Hz, 1 H, ArH), 3.19 (m, 4 H, 2 × CH2); 13C NMR
[100 MHz, (CD3)2CO]: δ = 139.1 (C), 137.8 (C), 128.6 (C),
128.0 (CF3), 125.1 (CH), 125.0 (C), 122.9 (CH), 122.0 (CH),
121.3 (C), 119.3 (2 × CH), 118.5 (d, JC–F = 3.5 Hz, CH),
117.9 (C), 117.1 (q, JC–F = 4.2 Hz, CH), 116.3 (C), 112.7
(CH), 112.1 (CH), 27.0 (CH2), 26.6 (CH2). ESI-MS:
m/z (%) = 351 (100) [M + Na]+, 250 (7). ESI-HRMS: m/z
[M + Na]+ calcd for [C19H15F3N2 + Na]+: 351.1080; found:
351.1076.
Compound 1c: According to the general procedure, a
mixture of aldehyde 5, 2-iodo-4-methoxylaniline (6c; 72
mg, 0.29 mmol), DABCO (89 mg, 0.79 mmol) and
Pd(OAc)2 (3 mg, 0.013 mmol, 5 mol%) in DMF (2.0 mL)
was heated at 85 °C for 17 h. The title compound (17 mg,
0.059 mmol, 22% over two steps) was obtained after flash
chromatography (4:1) as a brown solid; mp 136 –140 °C. IR:
3400, 1484, 1454, 1435, 1335, 1294, 1266, 1207, 1168,
1093, 1052, 1030, 1008, 967, 923, 829, 811, 795, 770, 747
cm–1. 1H NMR (400 MHz, DMSO-d6): δ = 10.73 (s, 1 H,
NH), 10.57 (s, 1 H, NH), 7.57 (d, J = 7.8 Hz, 1 H, ArH), 7.34
(d, J = 8.0 Hz, 1 H, ArH), 7.22 (d, J = 8.7 Hz, 1 H, ArH),
7.13 (m, 2 H, 2 × ArH), 7.07 (td, J = 7.5, 0.9 Hz, 1 H, ArH),
6.97 (m, 2 H, 2 × ArH), 6.70 (dd, J = 8.7, 2.4 Hz, 1 H, ArH),
3.72 (s, 3 H, OMe), 3.05 (m, 4 H, 2 × CH2). 13C NMR
(100 MHz, DMSO-d6): δ = 152.9 (C), 136.3 (C), 131.4 (C),
127.6 (C), 127.3 (C), 122.9 (CH), 122.3 (CH), 120.8 (CH),
118.3 (CH), 118.1 (CH), 114.8 (C), 114.6 (C), 111.9 (CH),
111.3 (CH), 110.9 (CH), 100.2 (CH), 55.3 (OMe), 25.8
(2 × CH2). ESI-MS: m/z (%) = 313 (100) [M + Na]+, 143 (9).
ESI-HRMS: m/z [M + Na]+ calcd for [C19H18N2O + Na]+:
313.1311; found: 313.1315.
Compound 1d: According to the general procedure, a
mixture of aldehyde 5, 4-chloro-2-iodoaniline (6d; 49 mg,
0.193 mmol), DABCO (60 mg, 0.535 mmol) and Pd(OAc)2
(2 mg, 0.009 mmol, 5 mol%) in DMF (1.3 mL) was heated
at 85 °C for 18 h. The title compound (9 mg, 0.031 mmol,
17% over two steps) was obtained after flash
Compound 1g: According to the general procedure, a
mixture of aldehyde 5, 4-amino-3-iodobenzonitrile (6g; 71
mg, 0.29 mmol), DABCO (89 mg, 0.79 mmol) and
Pd(OAc)2 (3 mg, 0.013 mmol, 5 mol%) in DMF (2.0 mL)
was heated at 85 °C for 90 h. The title compound (24 mg,
0.085 mmol, 32% over two steps) was obtained after flash
chromatography (3:2) as a brown solid; mp 162–165 °C. IR:
3406, 2223, 1614, 1469, 1456, 1422, 1361, 1322, 1221,
1098, 1082, 1066, 1008, 883, 827, 813, 801, 787, 764, 737
cm–1. 1H NMR (400 MHz, DMSO-d6): δ = 11.36 (s, 1 H,
NH), 10.74 (s, 1 H, NH), 8.05 (s, 1 H, ArH), 7.53 (m, 2 H,
2 × ArH), 7.37 (m, 3 H, 3 × ArH), 7.15 (s, 1 H, ArH), 7.06
(t, J = 7.5 Hz, 1 H, ArH), 6.97 (t, J = 7.5 Hz, 1 H, ArH), 3.08
(m, 4 H, 2 × CH2). 13C NMR (100 MHz, DMSO-d6): δ =
137.9 (C), 136.2 (C), 127.2 (C), 127.1 (C), 125.0 (CH),
124.3 (CH), 123.5 (CH), 122.4 (CH), 121.0 (C), 120.8 (CH),
118.4 (CH), 118.1 (CH), 116.2 (C), 114.4 (C), 112.5 (CH),
111.3 (CH), 100.2 (C), 25.8 (CH2), 25.4 (CH2). ESI-MS:
m/z (%) = 308 (100) [M + Na]+. ESI-HRMS: m/z [M + Na]+
calcd for [C19H15N3 + Na]+: 308.1158; found: 308.1153.
Compound 1h: According to the general procedure, a
mixture of aldehyde 5, 2-iodo-5-nitroaniline (6h; 77 mg,
0.29 mmol), DABCO (89 mg, 0.79 mmol) and Pd(OAc)2 (3
mg, 0.013 mmol, 5 mol%) in DMF (2.0 mL) was heated at
85 °C for 20 h. The title compound (40 mg, 0.131 mmol,
50% over two steps) was obtained after flash
chromatography (7:3) as a brown solid; mp 175 –178 °C
(Lit.1b 178–180 °C). IR: 3397, 2907, 1454, 1421, 1394,
1328, 1299, 1283, 1251, 1214, 1091, 1043, 1007, 927, 895,
871, 797, 777, 768, 738 cm–1. 1H NMR (400 MHz, DMSO-
d6): δ = 10.96 (s, 1 H, NH), 10.74 (s, 1 H, NH), 7.55 (m, 2 H,
2 × ArH), 7.34 (m, 2 H, 2 × ArH), 7.24 (d, J = 2.2 Hz, 1 H,
ArH), 7.15 (d, J = 2.0 Hz, 1 H, ArH), 7.06 (m, 2 H,
2 × ArH), 6.97 (td, J = 7.3, 0.7 Hz, 1 H, ArH), 3.04 (s, 4 H,
2 × CH2). 13C NMR (100 MHz, DMSO-d6): δ = 136.2 (C),
134.6 (C), 128.4 (C), 127.2 (C), 124.2 (CH), 122.8 (C),
122.3 (CH), 120.8 (CH), 120.7 (CH), 118.3 (CH), 118.1
(CH), 117.6 (CH), 114.8 (C), 114.5 (C), 112.8 (CH), 111.3
(CH), 25.8 (CH2), 25.5 (CH2). ESI-MS: m/z (%) = 317 (100)
[M + Na]+, 143 (18). ESI-HRMS: m/z [M + Na]+ calcd for
[C18H1535ClN2 + Na]+: 317.0816; found: 317.0807.
Spectroscopic data is consistent with the literature.1b
Compound 1e: According to the general procedure, a
mixture of aldehyde 5, 4-fluoro-2-iodoaniline (6e; 46 mg,
0.194 mmol), DABCO (60 mg, 0.535 mmol) and Pd(OAc)2
(2 mg, 0.009 mmol, 5 mol%) in DMF (1.3 mL) was heated
at 85 °C for 60 h. The title compound (10 mg, 0.037 mmol,
21% over two steps) was obtained after flash
chromatography (7:3) as a brown solid; mp 200 – 220 °C
chromatography (7:3) as an orange solid; mp 170–173 °C.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2013, 24, 1931–1936